<!DOCTYPE html>
<html lang="en">
<head>
    <meta charset="UTF-8">
    <meta name="viewport" content="width=device-width, initial-scale=1.0">
    <title>Whole Body Checkup Report - Stomach Cancer Patient</title>
    <style>
        body {
            font-family: Arial, sans-serif;
            margin: 20px;
            line-height: 1.6;
        }
        h1, h2, h3 {
            color: #333;
        }
        .container {
            max-width: 800px;
            margin: auto;
            padding: 20px;
            border: 1px solid #ccc;
            border-radius: 8px;
            background-color: #f9f9f9;
        }
        table {
            width: 100%;
            border-collapse: collapse;
            margin-top: 20px;
        }
        th, td {
            padding: 10px;
            text-align: left;
            border-bottom: 1px solid #ddd;
        }
        th {
            background-color: #f2f2f2;
        }
    </style>
</head>
<body>

<div class="container">
    <h1>Whole Body Checkup Report</h1>
    
    <h2>Patient Information</h2>
    <p><strong>UID:</strong> 987654321</p>
    <p><strong>Date of Birth:</strong> March 22, 1975</p>
    <p><strong>Age:</strong> 49</p>
    <p><strong>Gender:</strong> Female</p>
    <p><strong>Date of Report:</strong> December 21, 2024</p>
    <p><strong>Date of Diagnosis:</strong> November 10, 2024</p>

    <h2>Diagnosis</h2>
    <p><strong>Type of Cancer:</strong> Gastric Carcinoma (Stomach Cancer)</p>
    <p><strong>Histological Type:</strong> Adenocarcinoma</p>

    <h2>Clinical Presentation</h2>
    <ul>
        <li>Persistent abdominal pain</li>
        <li>Nausea and vomiting</li>
        <li>Unintentional weight loss</li>
        <li>Dysphagia (difficulty swallowing)</li>
        <li>Anemia (fatigue and weakness)</li>
    </ul>

    <h2>Laboratory Results</h2>
    <table>
        <thead>
            <tr>
                <th>Test</th>
                <th>Result</th>
                <th>Normal Range</th>
            </tr>
        </thead>
        <tbody>
            <tr>
                <td>CBC (Complete Blood Count)</td>
                <td>Anemia present (Hemoglobin: 10 g/dL)</td>
                <td>13.5-17.5 g/dL (normal)</td>
            </tr>
            <tr>
                <td>Liver Function Test</td>
                <td>ALT elevated at 75 U/L</td>
                <td>< 40 U/L (normal)</td>
            </tr>
            <tr>
                <td>Cancer Antigen (CA) 19-9</td>
                <td>Elevated at 150 U/mL</td>
                <td>< 37 U/mL (normal)</td>
            </tr>
        </tbody>
    </table>

    <h2>Genetic Information</h2>
    <table>
        <thead>
            <tr>
                <th>Gene</th>
                <th>Description</th>
                <th>Cytogenetic Code/Alteration</th></tr></thead><tbody><tr><td>HER2 (ERBB2)</td><td>A receptor tyrosine kinase involved in cell growth; overexpression is associated with poor prognosis.</td><td>(17q12)</td></tr><tr><td>P53</td><td>A tumor suppressor gene; mutations are linked to various cancers including gastric.</td><td>-</td></tr><tr><td>K-RAS</td><td>A gene that produces a protein involved in cell signaling; mutations can indicate poor prognosis.</td><td>-</td></tr></tbody></table>

    <h2>Tumor Staging and Prognosis</h2>
    <p><strong>Tumor Stage:</strong> pT3 N1 M0 (Tumor invades the muscularis propria with regional lymph node involvement).</p>
    <p><strong>Prognosis:</strong> The five-year survival rate for stage III gastric cancer is approximately 20-30% depending on treatment response.</p>

    <h2>Treatment Plan</h2>
    <ul>
        <li><strong>Surgical Intervention:</strong></li>
        <ul>
            <li>Total Gastrectomy scheduled for January 15, 2025.</li>
        </ul>

        <li><strong>Chemotherapy Regimen:</strong></li>
        <ul>
            <li>Cisplatin and Fluorouracil combination therapy post-surgery.</li>
        </ul>

        <li><strong>Targeted Therapy:</strong></li>
        <ul>
            <li>If HER2 positive, consider Trastuzumab as part of treatment.</li></ul>

        </li>

        <!-- Add more treatment details as necessary -->
        
        </ul>

    </h2>
    <h2>Doctor's Appointment Dates</h2>
    <table>
        <thead>
            <tr>
                <th>Date</th>
                <th>Time</th>
                <th>Description</th></tr></thead><tbody><tr><td>December 28, 2024</td><td>10:00 AM</td><td>Surgical Consultation with Dr. John Doe</td></tr><tr><td>January 10, 2025</td><td>09:30 AM</td><td>Chemotherapy Pre-Assessment with Oncology Nurse</td></tr></tbody></table>

    <h2>Recommendations</h2>
    <ul>
        <li>Avoid irritants such as alcohol and tobacco.</li>
        <li>Follow a nutrient-rich diet to support recovery post-surgery.</li>
        <li>Pain management and psychological support during treatment.</li></ul>

    </ul>

    <!-- Doctor's Signature -->
    <h3>Doctor's Signature:</h3>
    <p><strong>Dr. John Doe, MD</strong></p>

</div>

</body>
</html>

